SCIENTIFIC KNOWLEDGE VALUED AT $250 BILLION NOW AVAILABLE FOR ANYONE

We are in fact a big brain that stores and disseminates scientific knowledge through blockchain. The blockchain will alter the very notion of scientific heritage by making it protected and publicly available.

Project mission

In our world of a massive flow of information thousands of scientists are still unaware of what their colleagues are busy with. Our aim is to ensure a solid link between all scientists of the world by providing a platform for exchange of scientific knowledge in various fields.

We are convinced that strength is unity and therefore collective knowledge promotes new discoveries for the benefit of humankind.

_____________________

ICO - 60 000 ETH

PRE-ICO - 3000 ETH

130 ETH

TRADE ON KNOWLEDGE OR INVEST INTO RESEARCH

Though we do not know which class of investors you belong to ideologically, we want you to receive profit. That’s why we offer you to buy tokens 30% cheaper than the listed ICO price.

USE TOKENS

The tokens will be further used to pay for platform services that enable access to scientific papers.

PLATFORM STRUCTURE AND USER CASES

Our ecosystem is fed by a large number of scientific research, public data and clinical results transmitted to blockchain. This provides a unique opportunity for deep learning and to identify the logic of inquiries in order to structure knowledge precisely and search for new materials.

Users

The platform splits the users into two categories – readers and content makers. Readers who have tokens ( and in the future coins, too) use them to pay for subscriptions or quick access to scientific database.

Content makers receive crypto rewards for their content depending on the number of requests for their publications.

Miners

Miners store some part of registered scientific papers and provide their disc space and computing power for processing of information stored. A miner receives award each time a publication stored in his machine has been requested.

Servers

For distributed storage of data we use additional servers which ensure additional security of content.

Advertisers

Specific features of the platform make it possible to keep reading the content at a rather high level. These features provide an opportunity to monetize the audience by selling it to advertisers according to RTB model as well as DMP model ( we own the data). The advertiser pays for each screening of relevant native advertising in the context of a scientific paper.

Science

Our platform can buy subscriptions to a number of publishing houses and disseminate them among our blockchain participants or pay a reward each time a science paper placed on Global Sci has been requested. Publishing houses sell to our company subscription rights and receive awards when papers placed on the blockchain have been downloaded without fear of propagating a pirate content.

S computers

Data bases of scientific works are collected into a single body of 100 terabyte of data.
Registration data and search results are depersonalized and collected by Big Data platform which helps to target science papers and advertising. The ecosystem routes and processes texts while artificial intelligence works out algorithms for selection of relevant content. By analysing user experience we create really convenient innovations and interface.

Ask a CTO

WHY THIS PROJECT NEEDS BLOCKCHAIN SYSTEM

We plan to accumulate a database of scientific papers with the size of thousands of terabytes and the blockchain system is failure proof and secure.

We are going as well to use blockchain to process Globex Coin transactions in order to avoid unnecessary expenditure, to ensure operation of subsystems of mutual settlements with Globex Coin, and to verify history of transactions

Roadmap

2nd quarter of 2018

Creation of storage for scientific papers using our own servers on the basis of available Sci Hub database, optimizing text search in papers , setting up a prototype system of science paper storage in blockchain;

3d quarter 2018

Creation of subsystem for downloading of new papers and accounting for requests

1st quarter 2019

Creation of subsystem for collection of payment for accessing materials and subsystem for rewards to rights holders

2nd quarter 2019

Creation of Globex Coin and mechanism for development of our own tokens

4th quarter 2019

Universities that opened access to their publications receive access to scientific papers of other users

2018

Testing demand through main communication channels and conclusion of preliminary agreements with science communities and universities, working out communication strategy and advertising campaign for years 2018 – 2019

4th quarter 2018

Development of storage system for scientific papers on decentralized platform

2019

Involvement of three universities via direct sales and engagement of 200 000 science staff members, refinement of positioning, USP and improvement of product features, conclusion of contracts with main advertisers in pharmaceutical and biotechnological industries

3d quarter 2019

Identification of authors and rights holders of all available publications

2nd quarter of 2018

Creation of storage for scientific papers using our own servers on the basis of available Sci Hub database, optimizing text search in papers , setting up a prototype system of science paper storage in blockchain;

2018

Testing demand through main communication channels and conclusion of preliminary agreements with science communities and universities, working out communication strategy and advertising campaign for years 2018 – 2019

3d quarter 2018

Creation of subsystem for downloading of new papers and accounting for requests

4th quarter 2018

Development of storage system for scientific papers on decentralized platform

1st quarter 2019

Creation of subsystem for collection of payment for accessing materials and subsystem for rewards to rights holders

2019

Involvement of three universities via direct sales and engagement of 200 000 science staff members, refinement of positioning, USP and improvement of product features, conclusion of contracts with main advertisers in pharmaceutical and biotechnological industries

2nd quarter 2019

Creation of Globex Coin and mechanism for development of our own tokens

3d quarter 2019

Identification of authors and rights holders of all available publications

4th quarter 2019

Universities that opened access to their publications receive access to scientific papers of other users

FACTORS OF SUCCESS

Market

Target audience - over 50 million of health workers around the world, market volume over 250 billion US dollars

Trends

The project is at the crossroads of future 20 years of trends in: medicine, blockchain and big data

Demand and concerns

Proven demand for the project by major world universities and test results supporting industry concerns

Project founders

The project team is composed of scientists in the field of medicine, blockchain developers and top managers

Economics

Authors can receive rewards while preserving publication rights

THE TEAM OF FOUNDERS AND ADVISERS

Scientists and developers, founders and advisers connected by 15 years of collaboration.
We share common concern and aim – to unite scientists as a big community and open access to common body of knowledge.

ask Founders a question

News and publications

We actively involve the scientific community in the project. Scientists of the
world support the project and consider it significant. What do articles about us
and the topic of the information development of science in general

News and publications

We actively involve the scientific community in the project. Scientists of the
world support the project and consider it significant. What do articles about us
and the topic of the information development of science in general

Universities, research centers and well-known scientific journals that help the project and are ready to share knowledge with the whole world

Participate in PRE-ICO

Where can we meet

Join the project, ask questions, get acquainted personally with the founders and participants of the project at conferences around the world. Help us accelerate the development of science

Maps

FAQ

- What is Globex Sci?

Globex Sci is an ecosystem for storage and use of scientific papers allowing to exchange experience and knowledge and also to teach and launch neural network and AI products.

- Why is this project important for society?

We are in contact with major publishing houses and provide our platform for their archives for mutual benefit of all sides. Publishers get reward each time a paper has been requested and authors get their reward proportional to the number of references to their papers in other publications. In case a requested paper is mega popular, the author gets a reward that exceeds money spent for its publication.

- What significant problems can be solved by Globex Sci?

1. Limited access to publications caused by an absurd system of price formation for specialized scientific publications.
2. Unfair distribution of profit between the publisher and the author. Whereas in music, journalism, blogging and other intellectual pursuits authors of content get decent award, the author of a scientific paper has to pay for paper to be published.
3. Illegal distribution of publications via open access without rewarding the author. Sci-Hub, just one of known portals, provides 25 million papers in open access.

- Why is Blockchain technology used?

We plan to accumulate a database of scientific papers with the size of hundreds of terabytes while the blockchain system is failure proof and secure.

We are going as well to use blockchain to process Globex Coin transactions in order to avoid unnecessary expenditure , to ensure mutual settlements with Globex Coin, and to verify history of transactions.

- Who has an interest in Globex Sci and pay for using the platform?

The platform unites several interested parties. Users with tokens ( and further on, coins) can use them to pay for subscriptions or access to a scientific database. Content makers receive crypto award depending on the number of requests for publications. Miner gets a reward each time a publication stored in his machine has been requested. Profit for advertiser is ensured by a high level of involvement in content reading. Publishing houses get their share of profit when publications have been downloaded from the blockchain without fear of propagating pirate content

- What are key factors for success?

Potential audience is 50 million people and market size is over 250 billion dollars. Besides, the project is at the crossroads of the next 20 years in: medicine, blockchain and big data.

- Why does the project launch ICO and pre-ICO?

ICO has become the optimal method to attract investment for Globex Sci because this is the only way to achieve independence from private interests.

- How do users interact with the platform?

Clients have an opportunity to read publications without obstacles and also download their materials and receive award. Organizations have an opportunity to exchange inquiries and expand knowledge base. Publishing houses sell subscription rights and receive their share of profit when publications stored in blockchain have been downloaded without fear of propagating pirate content (of iTunes type)

- How can one invest in ICO?

Press the button “Join ICO” at front page of the site and follow the instructions.

- What is the investor’s profit in buying the token?

Token has a significant speculative potential: its value rises when demand for scientific publications grows.

- How will GSC token be used?

By using tokens one can pay for such services of the platform as storage of scientific documents , proof of authorship, storage of massive data sets, provision of paid access to data mass, distributed statistical analysis and mathematical procession of data, distributed machine learning, development of products such as external API, development of a platform to simulate biological systems.

- What currencies are available for investing? Can I invest fiat funds?

We accept currencies such as BTC, ETH. Investing of fiat funds has not been foreseen.

- Are there minimum and maximum levels of investment?

During pre-ICO the minimum amount of transaction is 0,1 ETH, while the maximum amount is limited only by the quantity of available tokens. During ICO minimum amount of transaction is 0,1 ETH while maximum amount is 1 000 ETH.

- How many tokens will be sold during pre-ICO and ICO? What happens with the unsold tokens?

During pre-ICO the quantity of available tokens amounts to 2 million GSI, during ICO – 30 million GSI. All unsold tokens will be annihilated.

- Will there be a chance to buy and sell tokens at stock exchange?

Yes.

- What is platform prototype?

A site can be utilized as MVP with a mass of publications accessible on Sci Hub. The site takes count of usage of publications necessary to collect data in order to further determine economics of the system, fee structure and so on.

- How do miners earn their share of profit?

A miner receives award each time a publication stored in his machine has been requested.

- How long will pre-ICO and ICO continue?

Pre-ICO: From 7 February 2018 to 7 March 2018, ICO: From 17 March 2018 to 17 April 2018.

- What is the financial target for ICO campaign?

The planned amount is 60,000 ETH. The minimum amount needed to launch the project is 3,000 ETH.

- Who can participate in ICO Globex SCI?

Tokens shall not be available for residents or citizens of the USA. Other limitations have not been foreseen.

Feedback on the project

Join the project, ask questions, get acquainted personally with the founders
and participants of the project at conferences around the world. Help us
accelerate the development of science

4. Question

Subscribe to news

Ask a CTO

THE TEAM OF FOUNDERS AND ADVISERS

Shamil Muggatarov

СЕО

Economist, political and public figure, several success companies in real estate management and development of biotechnologies

Nikolai Barlev

Chief Scientist

A scientist with more than 20 years of experience in the field of biomedicine.
For a long time he worked in Denmark, USA and Great Britain. Deputy Director
of the Institute of Cytology RAS, Doctor of Biological Sciences, Professor.
Editor of several journals Nature Publishing group. Editor-in-Chief of Cell Life and
Technology magazine.

Why is my experience important?
– Long experience of work in one of the largest publishing houses of the world
(Nature Publishing Group) allowed to really assess the information inequality
between the authors of articles and representatives of the publishing house.
– System thinking, the ability to structure and organize the work of specialists,
to collect and motivate a high-quality team to develop and launch new
technologies.
– Close cooperation with the world’s leading universities on scientific and
publishing issues publishing houses on the other hand, will provide a legal solution for the unequal access of
scientists to new and relevant knowledge.
– Economic knowledge in working with scientific developments will help
organize a self-sufficient scheme for the development of the platform.

Artur Teregulov

СТО

Blocking programmer. Organizer of a series of specialized meetups on the topic
of crypto-currency and block-technology. Participant of many hakatons.

Why is my experience important?
– Ability to organize the development of software, to find approaches to solving
complex and ambitious tasks, to motivate the team to achieve results and
ensure a high pace of development.
– Striving to use the most advanced IT technologies and new approaches to
development, to equal the highest industry standards.
– The experience of participation in various start-ups allows you to determine
the most effective ways to create a product, highlight its main value, and put it
on the market as soon as possible.

Il'ya Vinnikov

Developer

Blockchain teamlead is part of the CTO group.

Oleg Demidov

Adviser

Professor, Doctor of Medical Sciences, Head of Research Groups in Biotechnology and Genetics at the Institute of Health and Medical Research of INSERM U866 and University of Burgundy, Dijon, France.

Anastasia Demidova

Adviser

PhD in Medicine, INOVARION company, Head of Department for Research in Life Sciences , HOSPITAL SAINT-ANTOINE, INSERM UMRS 938, PARIS, FRANCE.

Gerry Melino

Adviser

Founder and Editor-in-Chief of four journals at Nature Publishing Group. Professor, Head of the Department of Experimental Medicine and Surgery, University of Rome, Italy, Science Consultant for Chanel International B.V.

Mauro Piacentini

Adviser

Professor, Head of the Department of Biochemistry, University of Rome Tor
Vergata, Rome, 00133, Italy,
Member of the Board of Directors of the University of Tor Vergata,
Editor of many international scientific journals.